RAPP - Company ID 0002012593
The table below shows Rapport Therapeutics, Inc.'s balance sheet line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Cash & equivalents | $52.65M | $56.80M |
| Short-term investments | $437.89M | $248.47M |
| Receivables | - | - |
| Inventory | - | - |
| Total current assets | $498.56M | $309.80M |
| Property, plant & equipment | $2.98M | $3.53M |
| Goodwill | - | - |
| Total assets | $512.43M | $314.93M |
| Accounts payable | $4.19M | $1.95M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current liabilities |
| $19.05M |
| $8.77M |
| Long-term debt | - | - |
| Total liabilities | $27.78M | $9.51M |
| Retained earnings | -$235.23M | -$123.75M |
| Total equity | $484.65M | $305.43M |